What Meta-analysis Can Tell You about the Performance of Bioanalytical Methods - Bioanalysis 2020

Ruben Ayala, CDER Office Translational Sciences, discusses bioanalytical data submitted to FDA, explores the utility of meta-analysis on bioanalytical data, shares an example of FDA inspection that used meta-analysis, identifies benefits and limitations of meta-analyses, and discusses future steps.
_______________________________
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.
Upcoming training and free continuing education credits: www.fda.gov/cd...
CDER SBIA 2020 Playlist: • 2020 CDER Small Busine...
LinkedIn: / cder-small-business-an...
Training resources: www.fda.gov/cd...
Twitter: / fda_drug_info
CDER small business e-mail update subscription: updates.fda.go...
Email: [e-mail]
Phone: [phone] I [phone]